These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 7802394)

  • 1. Cutaneous delayed hypersensitivity reactions of cattle vaccinated with mutant strains of Brucella abortus, using brucellins prepared from various brucellar strains.
    Cheville NF; Jensen AE; Morfitt DC; Stabel TJ
    Am J Vet Res; 1994 Sep; 55(9):1261-6. PubMed ID: 7802394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune responses and protection against infection and abortion in cattle experimentally vaccinated with mutant strains of Brucella abortus.
    Cheville NF; Stevens MG; Jensen AE; Tatum FM; Halling SM
    Am J Vet Res; 1993 Oct; 54(10):1591-7. PubMed ID: 8250382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serological findings obtained in cattle herds immunised with the Brucella melitensis Rev.1 and the B. abortus B19 vaccine in Mongolia.
    Dénes B
    Acta Vet Hung; 1997; 45(1):33-43. PubMed ID: 9270127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Field study of vaccination of cattle with Brucella abortus strains RB51 and 19 under high and low disease prevalence.
    Lord VR; Schurig GG; Cherwonogrodzky JW; Marcano MJ; Melendez GE
    Am J Vet Res; 1998 Aug; 59(8):1016-20. PubMed ID: 9706206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The efficacy of the skin delayed-type hypersensitivity using a Brucellin prepared from a mucoid strain of Brucella abortus to detect brucellosis.
    Bercovich Z; Muskens JA
    Vet J; 1999 Jan; 157(1):61-7. PubMed ID: 10030130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune responses and efficacy after administration of a commercial Brucella abortus strain RB51 vaccine to cattle.
    Olsen SC
    Vet Ther; 2000; 1(3):183-91. PubMed ID: 19757581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of age at vaccination on efficacy of Brucella abortus strain RB51 to protect cattle against brucellosis.
    Cheville NF; Olsen SC; Jensen AE; Stevens MG; Palmer MV; Florance AM
    Am J Vet Res; 1996 Aug; 57(8):1153-6. PubMed ID: 8836366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and immunogenicity of Brucella abortus strain RB51 vaccine in pregnant cattle.
    Palmer MV; Olsen SC; Cheville NF
    Am J Vet Res; 1997 May; 58(5):472-7. PubMed ID: 9140553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Field validation of the use of RB51 as antigen in a complement fixation test to identify calves vaccinated with Brucella abortus RB51.
    Adone R; Ciuchini F; Olsen S
    Clin Diagn Lab Immunol; 2001 Mar; 8(2):385-7. PubMed ID: 11238226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protection against infection and abortion induced by virulent challenge exposure after oral vaccination of cattle with Brucella abortus strain RB51.
    Elzer PH; Enright FM; Colby L; Hagius SD; Walker JV; Fatemi MB; Kopec JD; Beal VC; Schurig GG
    Am J Vet Res; 1998 Dec; 59(12):1575-8. PubMed ID: 9858409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of strain RB51 vaccine in heifers against experimental brucellosis.
    Poester FP; Gonçalves VS; Paixão TA; Santos RL; Olsen SC; Schurig GG; Lage AP
    Vaccine; 2006 Jun; 24(25):5327-34. PubMed ID: 16713034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of the complement fixation and brucellin skin tests to identify cattle vaccinated with Brucella abortus strain RB51.
    De Massis F; Giovannini A; Di Emidio B; Ronchi GF; Tittarelli M; Di Giannatale E; Di Ventura M; Nannini D; Caporale V
    Vet Ital; 2005; 41(4):291-9. PubMed ID: 20437382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Responses of adult cattle to vaccination with a reduced dose of Brucella abortus strain RB51.
    Olsen SC
    Res Vet Sci; 2000 Oct; 69(2):135-40. PubMed ID: 11020364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Allergic diagnosis of bovine brucellosis. 1. Conditions for the use of a purified protein allergen: brucellin (author's transl)].
    Fensterbank R; Pardon P
    Ann Rech Vet; 1977; 8(2):187-93. PubMed ID: 413466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differentiation of Brucella abortus and Yersinia enterocolitica serotype 09 infections in cattle: the use of specific lymphocyte transformation and brucellin skin tests.
    Chukwu CC
    Vet Q; 1987 Apr; 9(2):134-42. PubMed ID: 3113038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimation of the biological activity (potency) of batches of brucellin prepared from a mucoid strain of Brucella abortus.
    Bercovich Z; Tetenburg GJ; Eger A
    Vet Microbiol; 1998 Aug; 62(4):313-20. PubMed ID: 9791877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell-mediated immune response after Brucella abortus S19 vaccination.
    Klesius PH; Kramer TT; Swann AI; Christenberry CC
    Am J Vet Res; 1978 May; 39(5):883-6. PubMed ID: 103470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the brucellin skin test with the lymphocyte transformation test in bovine brucellosis.
    Chukwu CC
    J Hyg (Lond); 1986 Jun; 96(3):403-13. PubMed ID: 3734426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced efficacy of recombinant Brucella abortus RB51 vaccines against B. melitensis infection in mice.
    Vemulapalli R; Contreras A; Sanakkayala N; Sriranganathan N; Boyle SM; Schurig GG
    Vet Microbiol; 2004 Sep; 102(3-4):237-45. PubMed ID: 15327798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor necrosis factor-alpha in pregnant cattle after intravenous or subcutaneous vaccination with Brucella abortus strain RB51.
    Palmer MV; Elsasser TH; Cheville NF
    Am J Vet Res; 1998 Feb; 59(2):153-6. PubMed ID: 9492928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.